COVID-19 Related Resources
COVID-19 Related Publications, Webinars, Seminars and Other Resources
Standard BioTools™ continues to team up with researchers around the world who are working to mount an aggressive and sustainable response to the COVID-19 pandemic. Below are publications, recorded webinars and seminars and other resources relevant to COVID-19 research.
Trending Now | January 2022
This month’s edition features the latest in COVID-19 research. Since mass cytometry was quickly adopted to study the impact of SARS-CoV-2 infection soon after the virus appeared in 2020, investigators have successfully employed these technologies in a broad array of infectious disease applications.Read now
Download a complete summary of more than 50 publications using CyTOF technology to research COVID-19.See Bibliography
Webinar: A Multi-Omic Approach to Detection and Characterization of Viral Pathogens and Their Impact on the Immune System
Andrew Quong, PhD
Chief Science Officer
Bill Hunt, MS
Director, Microfluidics Product Management
Webinar: Detection of Human and Viral Full-Length RNA Using a Nanoscale Microfluidic Platform
Steve Kain, PhD
MBA Director, Genomics Product Management
- Profiling Three Layers of Human Immunity with CyTOF®, Olink® and Automated RNA-Seq | Petter Brodin discusses his multi-omics approach to understanding the human immune system.
- Bringing the Power of CyTOF to COVID-19 Research | Andrew Quong and Roberto Spada, both from Standard BioTools, describe the current use of mass cytometry in COVID-19 investigations.
- Profiling of COVID-19 Patient Immune Responses | Ruth Montgomery uses systems profiling to capture immune response to infection.
- Mapping Dynamic Immunity Across Time, Space, and Disease State | Tom Ashhurst uses mass cytometry and Imaging Mass Cytometry™ to better understand viral diseases of the central nervous system.
Get more information
Unless explicitly and expressly stated otherwise, all products are provided for Research Use Only, not for use in diagnostic procedures. Find more information here.